Detailed information about the course

[ Back ]
Title

Visit to Debiopharm

Dates

29 September 2022

Organizer(s)

Emilie Trachsel 

PhD student Dept. Microbiology & Molecular Medicine University of Geneva

Speakers
Description

Objectives:

Give the opportunity for PhD students to meet potential future employers, and understand practical aspects of the job directly on site.

Debiopharm (https://www.debiopharm.com/) is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. 50% of Debiopharm employees are former academics and Ingeneers.

Debiopharm is composed with 4 different societies:

1) Debiopharm International SA

2) Après-Demain SA

3) Debiopharm Innovation Fund SA in Lausanne

4) Debiopharm Research & Manufacturing SA in Martigny

The company propose a visit of the Research & Manufacturing SA society based in Martigny 

 

Program

Meeting at the Debiopharm lab, Martigny

  • 9h30 welcome (café-croissants) and presentation of Debiophram activities :

- Manufacture of controlled-release drugs such as: Decapeptyl®/Trelstar®/Pamorelin®, a drug for the treatment of advanced prostate cancer and certain hormone-dependent diseases in women

- Manufacture of controlled-release drugs such as: Fabiotic®, a drug for the treatment of bacterial infections)

  • 10h-11h visit (2 groups of 10)
  • 11h-11h30 Discussion and questions session
Location

Debiopharm Martigny

Information
Expenses

Travel expenses are covered by CUSO

Registration

Deadline 15.09.2022

Places

20

Deadline for registration 15.09.2022
Contact

In case of question, please write to us at microbiologie(at)cuso(dot)ch

short-url short URL

short-url URL onepage